139 related articles for article (PubMed ID: 32561481)
1. PDGFRβ plays an essential role in patient vitreous-stimulated contraction of retinal pigment epithelial cells from epiretinal membranes.
Yang Y; Huang X; Ma G; Cui J; Matsubara JA; Kazlauskas A; Zhao J; Wang J; Lei H
Exp Eye Res; 2020 Aug; 197():108116. PubMed ID: 32561481
[TBL] [Abstract][Full Text] [Related]
2. Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells.
Duan Y; Wu W; Cui J; Matsubara JA; Kazlauskas A; Ma G; Li X; Lei H
BMC Ophthalmol; 2023 Aug; 23(1):344. PubMed ID: 37537538
[TBL] [Abstract][Full Text] [Related]
3. PDGF receptors are activated in human epiretinal membranes.
Cui J; Lei H; Samad A; Basavanthappa S; Maberley D; Matsubara J; Kazlauskas A
Exp Eye Res; 2009 Mar; 88(3):438-44. PubMed ID: 19032953
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways.
Chan CM; Chang HH; Wang VC; Huang CL; Hung CF
PLoS One; 2013; 8(2):e56819. PubMed ID: 23457620
[TBL] [Abstract][Full Text] [Related]
5. Idelalisib inhibits vitreous-induced Akt activation and proliferation of retinal pigment epithelial cells from epiretinal membranes.
Xin T; Han H; Wu W; Huang X; Cui J; Matsubara JA; Song J; Wang F; Colyer M; Lei H
Exp Eye Res; 2020 Jan; 190():107884. PubMed ID: 31786159
[TBL] [Abstract][Full Text] [Related]
6. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.
Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299
[TBL] [Abstract][Full Text] [Related]
7. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy.
Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178
[TBL] [Abstract][Full Text] [Related]
8. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA
Commun Biol; 2019; 2():162. PubMed ID: 31069271
[TBL] [Abstract][Full Text] [Related]
9. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide 3-kinase δ inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells.
Han H; Chen N; Huang X; Liu B; Tian J; Lei H
J Biol Chem; 2019 Oct; 294(42):15408-15417. PubMed ID: 31467081
[TBL] [Abstract][Full Text] [Related]
11. Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.
Bastiaans J; van Meurs JC; van Holten-Neelen C; Nagtzaam NM; van Hagen PM; Chambers RC; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8306-14. PubMed ID: 24302586
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
[TBL] [Abstract][Full Text] [Related]
13. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
14. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro.
He S; Kumar SR; Zhou P; Krasnoperov V; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):543-52. PubMed ID: 19696168
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
[TBL] [Abstract][Full Text] [Related]
16. [The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy].
Liang Y; Li X; Fan J; Zhao M; Jiang Y
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):144-7. PubMed ID: 11955317
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
[TBL] [Abstract][Full Text] [Related]
18. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.
Amarnani D; Machuca-Parra AI; Wong LL; Marko CK; Stefater JA; Stryjewski TP; Eliott D; Arboleda-Velasquez JF; Kim LA
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3940-3949. PubMed ID: 28777835
[TBL] [Abstract][Full Text] [Related]
19. Growth factors outside the PDGF family drive experimental PVR.
Lei H; Velez G; Hovland P; Hirose T; Gilbertson D; Kazlauskas A
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3394-403. PubMed ID: 19324843
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy.
He S; Barron E; Ishikawa K; Nazari Khanamiri H; Spee C; Zhou P; Kase S; Wang Z; Dustin LD; Hinton DR
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5579-89. PubMed ID: 26305530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
